Inventor

ZENKE FRANK

DE33 patents

⚠️ This page may combine multiple inventors who share the name “ZENKE FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ZENKE FRANK

MERCK PATENT GMBH

Benzimidazole carboxamides as raf kinase inhibitors

Methylene urea derivatives

2-(hetero)-aryl substituted tetrahydroquinoline derivatives

Pyrrole derivatives

Cyclic amides as MetAP-2 inhibitors

Bipyridyl derivatives

Hetaryl-[1,8]naphthyridine derivatives

Phthalazinones

Substituted tetrahydroquinolines

Combination of a PD-1 antagonist, an ATR inhibitor and a platinating agent for the treatment of cancer

Tetrahydroquinolines

Oxindoles as kinase inhibitors

Pyrrolidinone derivatives as MetAP-2 inhibitors

Benzimidazole derivatives as raf kinase inhibitors

Glycinamide derivatives as raf-kinase inhibitors

HEINRICH TIMO

Pyrrolidone derivatives for use as MetAP-2 inhibitors

Pyrrolidinones as MetAP-2 inhibitors

Heterocyclic compounds as metap-2 inhibitors

JONCZYK ALFRED

Heteroarylaminoquinolines as TGF-beta receptor kinase inhibitors

Hetarylaminonaphthyridines

Hetaryl-[1,8]naphthyridine derivatives

SCHIEMANN KAI

Substituted tetrahydroquinolines

Tetrahydroquinolines for use as modulators of the mitotic motor protein Eg5

DORSCH DIETER

2,4-diaryl-substituted [1,8] naphthyridines as kinase inhibitors for use against cancer

Pyrido [2, 3-B] pyrazine compounds and their therapeutical uses such as for inhibiting ATP consuming proteins and treating diseases associated therewith

FUCHSS THOMAS

Imidazo[4,5-c]quinolines as DNA-PK inhibitors

Pyrazoloquinolines

MEDERSKI WERNER

Morpholinylquinazolines

HOELZEMANN GUENTER

Bipyridyl derivatives

MERCK PATENT GES MIT BESCHRANKTER HAFTUNG

Imidazo[4,5-C]quinolines as DNA-PK inhibitors

STAEHLE WOLFGANG

Tetrahydroquinoline derivatives

BUCHSTALLER HANS-PETER

Methylene urea derivatives

KELLNER ROLAND

Use of EEF1A as biomarker and a method of screening MetAP2 inhibitors